investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Large Databases of Small Molecules - Drug Development Tool and Public Resource

Marc Nicklaus

5 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Peter Ertl

Novartis (Switzerland)

Basel, Switzerland

Sorel Muresan

Lund University

Lund, Sweden

AstraZeneca (United Kingdom)

London, United Kingdom

Dmitry Katsubo

European Patent Office

The Hague, Netherlands

Related projects

Noelle Elizabeth Huskey Mullin

The Role of Primary Cilia in the Evolution of Drug Resistant Basal Cell Carcinoma

All cancers but non-melanoma skin cancer

Anatoly Zhitkovich

Formaldehyde Genotoxicity

All cancers but non-melanoma skin cancer

Cornelia Ursula Kunz

Novel biomarker based designs for late phase clinical trials

All cancers but non-melanoma skin cancer

Peter R Parham

Interactions Between HLA Class I and Cytolytic Lymphocytes

All cancers but non-melanoma skin cancer

Investigator from Heinrich Heine University Düsseldorf

Epidermal growth factor receptor (EGFR) activation by cytohesins - Structural Insights

All cancers but non-melanoma skin cancer

Antonio J Giraldez

Analysis of the gene networks regulating the maternal to zygotic transition

All cancers but non-melanoma skin cancer

Sriram Subramaniam

Molecular Structures of Membrane Protein Assemblies

All cancers but non-melanoma skin cancer

Joel Schneider

Design and Utility of Novel Proteinaceous Biomaterials 

All cancers but non-melanoma skin cancer

Pathology

Scott Henry Olejniczak

Reciprocal regulation of microRNAs and cancer-associated signaling pathways

All cancers but non-melanoma skin cancer